5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stimulation of epidermal growth factor (EGFR) or HER-3 mediates resistance to MET tyrosine kinase inhibition in MET-amplified gastric cancer cells
    Meeting Abstract

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. L.; Tang, L.; Song, L.; Zeng, Z.; Shah, M.; Christensen, J. G.; Rosen, N.; Solit, D. B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Ovarian cancer associated T cell coinhibitory B7-H3 and B7x
    Meeting Abstract

    Zang, X.; Soslow, R. A.; Waitz, R.; Reuter, V. E.; Wilton, A.; Thaler, H. T.; Arul, M.; Slovin, S. F.; Wei, J.; Dupont, J.; more...
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • Ovarian cancer associated T cell coinhibitory B7-H3 and B7x
    Meeting Abstract

    Zang, X.; Soslow, R. A.; Waitz, R.; Reuter, V. E.; Wilton, A.; Thaler, H. T.; Arul, M.; Slovin, S. F.; Wei, J.; Dupont, J.; more...
    Modern Pathology (2008)

    Fulltext@MSK | Save
  • Gastric carcinomas with lymphoid stroma show distinct molecular features that reflect their Epstein-Barr virus (EBV) and microsatellite instability (MSI) status
    Meeting Abstract

    Young, G. Q.; Shia, J.; Tang, L. H.; Klimstra, D. S.; Chen, Y.; Yantiss, R. K.
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • Triple suicide gene therapy radiosensitizes prostate cancer cells
    Meeting Abstract

    Xing, L.; Sun, X.; Deng, X.; Koutcher, J.; Ling, C.; Li, G.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Hypoxia-inducible factor (HIF) and mammalian target of rapamycin (mTOR) pathways in invasive urothelial carcinoma of the bladder: An immunohistochemical (IHC) study with potential therapeutic implications
    Meeting Abstract

    Tickoo, S. K.; Milowsky, M. I.; Fine, S. W.; Gopalan, A.; Dudas, M.; Dhar, N.; Gallagher, D.; Bajorin, D. F.; Reuter, V. E.
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • Hypoxia-inducible factor (HIF) and mammalian target of rapamycin (mTOR) pathways in invasive urothelial carcinoma of the bladder: An immunohistochemical (IHC) study with potential therapeutic implications
    Meeting Abstract

    Tickoo, S. K.; Milowsky, M. I.; Fine, S. W.; Gopalan, A.; Dudas, M.; Dhar, N.; Gallagher, D.; Bajorin, D. F.; Reuter, V. E.
    Modern Pathology (2008)

    Fulltext@MSK | Save
  • HGF/MET rescues Gefitinib treated non-small cell lung cancer cells carrying an activating EGFR mutation
    Meeting Abstract

    Sun, M. Y.; Bachleitner-Hofmann, T.; Chen, C. T.; Solit, D. B.; Weiser, M. R.
    Journal of the American College of Surgeons (2008)

    Fulltext@MSK | Save
  • Potent anticancer activity of panobinostat (LBH589) in models of hormone-refractory prostate cancer (HRPC): Targeting the androgen receptor
    Meeting Abstract

    Shao, W.; Growney, J.; O'Connor, G.; Feng, Y.; Scher, H.; Yao, Y. M.; Fawell, S.; Atadja, P.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortium
    Meeting Abstract

    Scher, H.; Beer, T.; Higano, C.; Logothetis, C.; Shelkey, J.; Hung, D.; Hirmand, M.; Larson, S.; Fleisher, M.; Sawyers, C.
    EJC Supplements (2008)

    Fulltext@MSK | Save